YMAB - Y-Mabs Therapeutics Inc
IEX Last Trade
14.31
0.290 2.027%
Share volume: 240,613
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$14.02
0.29
2.07%
Summary score
24%
Profitability
25%
Dept financing
5%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.89%
Return on assets
-12.04%
Return on sales
-180.38%
Return on invested capital
124.22%
Total debt ratio
17.99%
Debt ratio change over timeo
-1.09%
Current Ratio
7.11%
Quick Ratio
6.69%
Cash Position Ratio
6.26%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-5.35%
Return on assets
-4.89%
Return on sales
-30.26%
Return on invested capital
117.68%
Total debt ratio
20.95%
Debt ratio change over timeo
-0.74%
Current Ratio
5.43%
Quick Ratio
5.11%
Cash Position Ratio
3.95%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-6.68%
Return on assets
-5.6%
Return on sales
-34.66%
Return on invested capital
259.25%
Total debt ratio
19.56%
Debt ratio change over time
-0.33%
Current Ratio
6.15%
Quick Ratio
5.67%
Cash Position Ratio
4.3%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-82.99%
Return on assets
-89.64%
Return on sales
26.1%
Return on invested capital
-117.04%
Total debt ratio
-108.85%
Debt ratio change over time
-1.09%
Current Ratio
0.12%
Quick Ratio
-0.13%
Cash Position Ratio
-0.22%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | YMAB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.89% | 13.79% | 34.47% | 7.43% |
| Return on assets | -12.04% | 2.76% | 3.15% | 5.62% |
| Return on sales | -180.38% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 124.22% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 41% | 60% | 59% |
| Total debt ratio | 17.99% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.09% | 308.97% | -6.99% | 1.18% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 5.43% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.11% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.95% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 16% | 38% |
| Short-term ratios | YMAB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.35% | 13.77% | 13.25% | 3.8% |
| Return on assets | -4.89% | 2.43% | 1.89% | 3.09% |
| Return on sales | -30.26% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 117.68% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 60% | 59% |
| Total debt ratio | 20.95% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.74% | 46.38% | -72.08% | 1.51% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 5.43% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.11% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.95% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 10% | 27% | 66% |